IvyRx GLP-1 Review 2026: Flat-Rate Compounded Semaglutide & Tirzepatide at $175 to $297/mo
IvyRx offers compounded semaglutide from $175/month and tirzepatide from $275/month with a rare flat-rate model, your price never increases as your dose goes up. We reviewed their pricing, clinical oversight, and transparency. Key finding: the flat-rate pricing is genuinely valuable, but IvyRx doesn't publicly disclose a named medical director or their compounding pharmacy partners, which are meaningful gaps for patients who want to verify clinical quality.
Published provider headline prices with starting and recurring terms preserved.
Affiliate links, we earn a commission at no extra cost to you. Commercial placement; see the full price-sorted comparison on our rankings page.
Summarize this article with
IvyRx offers compounded semaglutide from $175/month and tirzepatide from $275/month with a flat-rate pricing model, your monthly cost stays the same regardless of which dose you're on. That's a genuine differentiator: most compounders charge $100 to $150 more per month at higher maintenance doses, so over a full year the flat-rate model can save $600 to $1,200 compared to dose-tiered competitors. Where IvyRx falls short is clinical transparency: there's no named medical director on the public website, no disclosed compounding pharmacy, and no required lab work before prescribing. For patients who want to verify who is overseeing their care, those gaps matter. Here's what you need to know as of May 2026.
Comparing your options?
See every verified GLP-1 program ranked side by side on cost, safety, and care quality. The cheapest we track right now is $69/mo.
Compare all 54 GLP-1 providers →Quick Verdict
Pricing: The Flat-Rate Advantage
IvyRx keeps pricing simple: one flat monthly rate for each medication, regardless of dose. That structure is rare in the telehealth GLP-1 market, where most platforms charge on a dose-tiered basis, meaning your cost rises from starting dose ($99 to $199/mo) to maintenance dose ($299 to $449/mo) as you escalate.
| Program | Monthly Price | Notes |
|---|---|---|
| Compounded Semaglutide (standard) | $175 to $197/mo | Flat rate, same price at 0.25mg, 0.5mg, 1mg, 2mg doses. No membership fee. |
| Compounded Semaglutide (microdose) | $155/mo | 4 doses per month, lower entry point for sensitive patients or those re-starting |
| Compounded Tirzepatide (standard) | $275 to $297/mo | Flat rate across all tirzepatide dose levels. Starting and maintenance at same price. |
| Initial consultation | Free | Consultation included, you only pay for the medication |
| Shipping | Included | Free shipping with every order |
For context: Sprout Health charges $199 for the first month, then $249/month all-inclusive (medication, shipping, all consultations). Enhance MD offers $49 first month then $212/month for semaglutide. IvyRx's flat rate lands above the lowest entry points but below where most competitors settle at maintenance dose.
IvyRx accepts HSA/FSA payments and provides an itemized receipt for reimbursement. There is no membership fee separate from the medication cost, one payment covers medication, consultations, and shipping.
Join the list for the GLP-1 Letter.
We re-verify every price on this site against the provider's own live page and check every program against the FDA warning letter database. Join the list and you will hear from us when that work turns up something worth an email. No promised schedule until we are actually keeping one. Unsubscribe anytime.
No affiliate spam. No retargeting pixels. Unsubscribe in one click.
Medications Offered
- •Compounded semaglutide (injectable), standard doses and microdose variants
- •Compounded tirzepatide (injectable), flat-rate across all dose tiers
- •Microdose GLP-1 program, four-dose packs at $155/month; suited for patients with high GI sensitivity or those re-starting after a pause
- •No brand-name GLP-1s listed, IvyRx is a compounding-only program. If you need FDA-approved Wegovy or Zepbound, you'll need a different provider.
IvyRx's menu is narrower than platforms like Hers (Novo Nordisk partnership for brand-name Wegovy) or Fridays, which manage brand-name insurance access alongside compounded options. If there's any chance you'll want to switch to brand-name (for insurance coverage, the SELECT cardiovascular indication, or when compounded options narrow further under the FDA 503B exclusion proposal), a provider with both tracks is worth considering.
Editor's Top Pick
Embody
from $69/mo · 7.3/10 · Compounded
Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan. Its standout is oral tirzepatide gum for people who do not want injections.
Clinical Oversight: What's Public vs. What's Missing
IvyRx was founded by a clinical pharmacist and works with licensed US 503A compounding pharmacies. Processing time is typically 2-3 business days. All affiliated providers are described as board-certified US-licensed healthcare professionals.
What IvyRx does NOT publicly disclose:
- •Named medical director, No publicly named physician with verifiable NPI or state license on the About page. This is a transparency gap; platforms like Yucca Health (Dr. Michael Wasef MD and Dr. Andrew Sakla DO) and Sprout Health (named clinical team with dedicated care coordinator) name their clinical leadership in a way IvyRx does not.
- •Compounding pharmacy partner, The 503A pharmacies used to fill prescriptions are not named on the site. You cannot independently verify PCAB accreditation or LegitScript certification of the specific pharmacy. IvyRx states the 503A category, while Embody names four facilities but does not publish which 503A or 503B role applies to a particular prescription. The two disclosures answer different questions, and IvyRx still leaves the facility identity unresolved.
- •Required baseline labs, IvyRx does not require bloodwork before prescribing. A responsible compounding program should assess baseline metabolic markers (HbA1c, kidney function) before starting a GLP-1, particularly for patients with undiagnosed type 2 diabetes or contraindications.
Not sure which GLP-1 program is right for you?
Take the 60-second quiz, we'll match you against 54 verified providers on your goals, budget, and medication preference, then surface your top 3.
Take the 60-sec QuizHow IvyRx Compares to Alternatives
| Provider | Semaglutide (ongoing) | Tirzepatide (ongoing) | Named Medical Director | Labs Required |
|---|---|---|---|---|
| IvyRx | $175 to $197/mo (flat) | $275 to $297/mo (flat) | Not disclosed | Not required |
| Sprout Health | $249/mo (all-inclusive) | $249/mo (all-inclusive) | Yes, named clinical team + dedicated care coordinator | Optional |
| Enhance MD | $212/mo | $280/mo | Partial, provider team listed | Varies |
| Fridays | $240/mo (12-mo plan) | $240/mo (12-mo plan) | Yes, disclosed | Yes |
| Henry Meds | $197 to $397/mo (tiered) | $199 to $349/mo (tiered) | Mixed (multiple staff named in reviews) | Not required |
Henry Meds starts at $197/mo for low-dose semaglutide, similar to IvyRx, but scales to $397/mo at the highest dose, while IvyRx stays flat. That's where the flat-rate model delivers real savings for patients who reach higher maintenance doses.
Who IvyRx Is Best For
- •Re-starters: If you've done a GLP-1 program before, had labs done elsewhere, and just want a straightforward flat-rate refill, IvyRx's simple model works
- •High-dose patients: If your provider has already titrated you to a higher dose and you're looking for a lower ongoing cost than your current program, IvyRx's flat rate may undercut competitors by $100+/mo
- •Budget-focused microdosers: The $155/month microdose program is one of the lower entry points in the market for patients who need a gradual start
- •NOT recommended for first-time GLP-1 patients: Without required labs or a named medical director, the clinical safety net is thinner than what's standard at higher-rated providers. Use our match quiz to find a better-vetted starting point.
Verdict
IvyRx's flat-rate pricing is legitimately differentiated, it's one of the few compounders that won't increase your monthly bill as your dose escalates. For cost-savvy patients who are already experienced with compounded GLP-1s, it's worth comparing directly against your current program.
The transparency gaps are real, though. A provider that doesn't publicly name its medical director or compounding pharmacy is asking patients to take more on trust than the alternatives require. If you're starting GLP-1 therapy for the first time, we recommend prioritizing a provider that discloses its clinical leadership and operating track record. Yucca Health ($146/mo on the 6-month plan, two named board-certified doctors, 4.6★ across 1,065 Trustpilot reviews) and Enhance MD ($212/mo ongoing, $49 first month) are better-vetted alternatives at similar price points.
Use our cost calculator to run the flat-rate math against your current program over 12 months, or take the match quiz to find the best-fit provider for your clinical situation and budget.
Medical disclaimer: This review is for informational purposes only and does not constitute medical advice. Compounded GLP-1 medications are not FDA-approved finished pharmaceutical products. Compounded semaglutide is subject to legal status changes as FDA enforcement evolves, see our compounding ban guide for the latest. Never start, stop, or change a GLP-1 medication without consulting a licensed healthcare provider.
Sources
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Information is current as of the publication date but may change.
Affiliate Disclosure: Some links in this article are affiliate links. We may earn a commission if you sign up through our links, at no extra cost to you.
Done comparing? Our Top Pick is Embody
Our featured pick, scored 7.3/10 by our methodology, is listed at from $69/mo. Not sure it's the one for you? The 60-second quiz matches you to your budget and medication.
Featured affiliate pick, we may earn a commission · scores set by our methodology, not payment
Compare every GLP-1 program in one place
See all 54 verified providers ranked side by side on price, medication, and our independent score, or jump straight to the cheapest verified prices.
Ozempic Plateau: Why You Stopped Losing Weight
GuidesGLP-1 Storage and Travel: Heat, TSA Rules, and What to Do If It Was Left Out
GuidesGLP-1 Receptor Agonists for Weight Loss 2026: FDA-Approved Options, Cost & Prescription Guide
Keep exploring
- →Provider Rankings
- →Cheapest Providers
- →Take the Match Quiz
- →Weight Loss Predictor
- →Full Cost Guide
- →Cost Calculator
What the doctors say
Verbatim, independently sourced statements from named physicians and medical bodies, real clinicians quoted with their sources, not a single paid reviewer. General clinical context, not an endorsement of any provider.
“So-called 'weight loss drugs' like semaglutide have proven benefits beyond reducing the number on the scales. They are now considered important medicines for preventing deadly heart attacks and strokes. Today's guidance will no doubt help save lives as cardiovascular disease is still one of the country's biggest killers.”
“While compounding can play an appropriate role when used to meet the specific needs of an individual patient, the large-scale production and marketing of compounded versions of these medicines raises serious safety risks when products have not undergone the rigorous scientific and regulatory review required for FDA-approved therapies.”
“It's not just filling out a form online and then having some random healthcare provider sign off on it. There are concerns with some of these online programs that there's not a proper evaluation, there's not a baseline, and there's not proper supervision.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.